These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 31070303)

  • 1. Comprehensive characterization of cancer-testis genes in testicular germ cell tumor.
    Chang Y; Wang X; Xu Y; Yang L; Qian Q; Ju S; Chen Y; Chen S; Qin N; Ma Z; Dai J; Ma H; Jin G; Zhang E; Wang C; Hu Z
    Cancer Med; 2019 Jul; 8(7):3511-3519. PubMed ID: 31070303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of piRNA biogenesis and function in testicular germ cell tumors and their precursor germ cell neoplasia in situ.
    Gainetdinov IV; Skvortsova YV; Kondratieva SA; Klimov A; Tryakin AA; Azhikina TL
    BMC Cancer; 2018 Jan; 18(1):20. PubMed ID: 29301509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Non-Coding RNA RFPL3S Functions as a Biomarker of Prognostic and Immunotherapeutic Prediction in Testicular Germ Cell Tumor.
    Guo J; Wang S; Jiang Z; Tang L; Liu Z; Cao J; Hu Z; Chen X; Luo Y; Bo H
    Front Immunol; 2022; 13():859730. PubMed ID: 35669771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor 2 (TLR2) is a candidate prognostic factor in testicular germ cell tumors as well as an indicator of immune function in the tumor microenvironment.
    Wu H; Zhang Z; Xiao XY; Zhang ZY; Gao SL; Lu C; Zuo L; Zhang LF
    Bioengineered; 2021 Dec; 12(1):1939-1951. PubMed ID: 34002664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wilms tumor gene 1 (WT1), TP53, RAS/BRAF and KIT aberrations in testicular germ cell tumors.
    Boublikova L; Bakardjieva-Mihaylova V; Skvarova Kramarzova K; Kuzilkova D; Dobiasova A; Fiser K; Stuchly J; Kotrova M; Buchler T; Dusek P; Grega M; Rosova B; Vernerova Z; Klezl P; Pesl M; Zachoval R; Krolupper M; Kubecova M; Stahalova V; Abrahamova J; Babjuk M; Kodet R; Trka J
    Cancer Lett; 2016 Jul; 376(2):367-76. PubMed ID: 27085458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant epigenetic inactivation of RASSF1A and MGMT gene and genetic mutations of KRAS, cKIT and BRAF in Indian testicular germ cell tumours.
    Ahmad F; Surve P; Natarajan S; Patil A; Pol S; Patole K; Das BR
    Cancer Genet; 2020 Feb; 241():42-50. PubMed ID: 31653608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling of the small RNA populations in human testicular germ cell tumors shows global loss of piRNAs.
    Rounge TB; Furu K; Skotheim RI; Haugen TB; Grotmol T; Enerly E
    Mol Cancer; 2015 Aug; 14():153. PubMed ID: 26265322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNAs and Biomarkers in Testicular Germ Cell Tumors: An Update.
    De Martino M; Chieffi P; Esposito F
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant testicular germ cell tumors in postpubertal individuals with androgen insensitivity: prevalence, pathology and relevance of single nucleotide polymorphism-based susceptibility profiling.
    Cools M; Wolffenbuttel KP; Hersmus R; Mendonca BB; Kaprová J; Drop SLS; Stoop H; Gillis AJM; Oosterhuis JW; Costa EMF; Domenice S; Nishi MY; Wunsch L; Quigley CA; T'Sjoen G; Looijenga LHJ
    Hum Reprod; 2017 Dec; 32(12):2561-2573. PubMed ID: 29121256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypomethylation-driven AKT Serine/Threonine Kinase 3 promotes testicular germ cell tumors proliferation and negatively correlates to immune infiltration.
    Luo Y; Zhou Q; Zhu F; Fan L; Bo H; Wang X
    Bioengineered; 2021 Dec; 12(2):11288-11302. PubMed ID: 34882061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functions of genes related to testicular germ cell tumour development.
    Das MK; Kleppa L; Haugen TB
    Andrology; 2019 Jul; 7(4):527-535. PubMed ID: 31310060
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Liu Z; Fang B; Cao J; Zhou Q; Zhu F; Fan L; Xue L; Huang C; Bo H
    Bioengineered; 2022 May; 13(5):12141-12155. PubMed ID: 35575252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of splicing variants of the inhibitor of apoptosis livin in testicular germ cell tumors.
    Kempkensteffen C; Hinz S; Krause H; Jager T; Köllermann J; Weikert S; Christoph F; Schostak M; Miller K; Schrader M
    Tumour Biol; 2008; 29(2):76-82. PubMed ID: 18515985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression levels of the IAP antagonists XAF1, Smac/DIABLO and HtrA2 in testicular germ cell tumours].
    Kempkensteffen C; Hinz S; Jäger T; Weikert S; Krause H; Schostak M; Christoph F; Strenziok R; Miller K; Schrader M
    Aktuelle Urol; 2008 Nov; 39(6):436-41. PubMed ID: 18979398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testicular Germ Cell Tumor Tissue Biomarker Analysis: A Comparison of Human Protein Atlas and Individual Testicular Germ Cell Tumor Component Immunohistochemistry.
    Krasic J; Skara Abramovic L; Himelreich Peric M; Vanjorek V; Gangur M; Zovko D; Malnar M; Masic S; Demirovic A; Juric B; Ulamec M; Coric M; Jezek D; Kulis T; Sincic N
    Cells; 2023 Jul; 12(14):. PubMed ID: 37508506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma.
    Biermann K; Göke F; Nettersheim D; Eckert D; Zhou H; Kahl P; Gashaw I; Schorle H; Büttner R
    J Pathol; 2007 Nov; 213(3):311-8. PubMed ID: 17768701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of mRNA Prognostic Markers for TGCT by Integration of Co-Expression and CeRNA Network.
    Zhu F; Liu Z; Zhou Q; Fan J; Zhou D; Xing L; Bo H; Tang L; Fan L
    Front Endocrinol (Lausanne); 2021; 12():743155. PubMed ID: 34621245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-Analysis of Gene Expressions in Testicular Germ Cell Tumor Histologies.
    von Eyben FE; Parraga-Alava J
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genomic landscape of testicular germ cell tumours: from susceptibility to treatment.
    Litchfield K; Levy M; Huddart RA; Shipley J; Turnbull C
    Nat Rev Urol; 2016 Jul; 13(7):409-19. PubMed ID: 27296647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model based on tumor-infiltrating immune cells for predicting the relapse rates of patients with testicular germ cell tumors.
    Wang Y; Ji C; Liu J; Wang Y; Song N; Cao P
    Int Immunopharmacol; 2020 Sep; 86():106710. PubMed ID: 32652500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.